Article
5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms.
European journal of pharmacology - 2 Feb 2008
Velati Daniela, Viana Michele, Cresta Stefania, Mantegazza Paola, Testa Lucia, Bettucci Diego, Rinaldi Maurizio, Sances Grazia, Tassorelli Cristina, Nappi Giuseppe, Canonico Pier Luigi, Martignoni Emilia, Genazzani Armando A
Abstract excerpt
Triptans mediate vasoconstriction of meningeal vessels via stimulation of vascular 5-hydroxytryptamine (5-HT)(1B) receptors. These drugs are recommended for acute treatment in patients with moderate-to-severe migraine attacks and in those patients with mild-to-moderate headache that are not controlled adequately by other agents. Yet, approximately 25% of all migraine users and 40% of all attacks do not respond to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
